Literature DB >> 11557033

Genomic organization and embryonic expression of Suppressor of Fused, a candidate gene for the split-hand/split-foot malformation type 3.

T Grimm1, S Teglund, D Tackels, E Sangiorgi, F Gurrieri, C Schwartz, R Toftgård.   

Abstract

The genes for human and mouse Suppressor of Fused (SU(FU)/Su(Fu)) in the Hedgehog signaling pathway were characterized and found to contain 12 exons. Human SU(FU) localized on chromosome 10q24-25 between the markers D10S192 and AFM183XB12. We detected three additional SU(FU) isoforms, two of which have lost their ability to interact with the transcription factor GLI1. Expression analysis using whole mount in situ hybridization revealed strong expression of Su(Fu) in various mouse embryonic tissues. SU(FU) was considered a candidate gene for the split-hand/split-foot malformation type 3 (SHFM3). However, no alterations in the SU(FU) gene were found in SHFM3 patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557033     DOI: 10.1016/s0014-5793(01)02682-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Suppressor of fused regulates Gli activity through a dual binding mechanism.

Authors:  Mark Merchant; Felix F Vajdos; Mark Ultsch; Henry R Maun; Ulrich Wendt; Jennifer Cannon; William Desmarais; Robert A Lazarus; Abraham M de Vos; Frederic J de Sauvage
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  The negative regulator of Gli, Suppressor of fused (Sufu), interacts with SAP18, Galectin3 and other nuclear proteins.

Authors:  Mélanie Paces-Fessy; Dominique Boucher; Emile Petit; Sandrine Paute-Briand; Marie-Françoise Blanchet-Tournier
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

3.  Novel mechanism of action on Hedgehog signaling by a suppressor of fused carboxy terminal variant.

Authors:  Ulrica Tostar; Csaba Finta; Mohammed Ferdous-Ur Rahman; Takashi Shimokawa; Peter G Zaphiropoulos
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.